📊 This is a company profile preview from Tablestat.com Request a Free Trial Now

Company profile: Selecta Biosciences

1.1 - Company Overview

Selecta Biosciences Logo

Selecta Biosciences

Headquarter: United States
Founded: 20XX🔒
Employees: 100-500🔒

Company description

  • Provider of clinical-stage biotechnology focused on overcoming immunogenicity.

Products and services

🔒

Key contacts

🔒
🔒

Financial details

🔒

1.2 - Competitors and similar companies to Selecta Biosciences

SNIPR Biome Logo

SNIPR Biome

HQ: Denmark Website
  • Description: Provider of CRISPR-based microbial gene therapies that selectively target and eliminate hazardous bacteria without harming beneficial microbes; gut-directed gene therapy via engineered bacteria; CRISPR-Guided Vectors (CGV) for rapid, precise bacterial killing; platforms for in situ therapeutic protein and peptide production; backed by an extensive patent portfolio and research collaborations.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full SNIPR Biome company profile →
QuantRx Biomedical Logo

QuantRx Biomedical

HQ: United States Website
  • Description: Provider of diagnostic products for the healthcare industry, focusing on their development and commercialization.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full QuantRx Biomedical company profile →
Senti Bio Logo

Senti Bio

HQ: United States Website
  • Description: Provider of synthetic biology-driven cell and gene therapies for cancer, featuring a Gene Circuit platform to program therapies, off-the-shelf CAR-NK cell therapies, and investigational candidates SENTI-202 (logic-gated targeting of CD33/FLT3 for hematologic malignancies incl. AML) and SENTI-301A (for GPC3+ tumors with crIL-15 Gene Circuit), with manufacturing via GeneFab.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Senti Bio company profile →
Yecuris Logo

Yecuris

HQ: United States Website
  • Description: Provider of FRG KO liver-humanized mouse models and tools for applications including gene editing, drug metabolism, toxicology, and liver disease. Offers HepaCur human hepatocytes (fresh/cryopreserved), CuRx reagents for the FRG KO platform, gene and cell therapy services (in vitro/in vivo validation, custom hepatocyte transplantation), plus NASH/NAFLD and infectious disease models; reagents ship worldwide.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Yecuris company profile →
Eligo Bioscience Logo

Eligo Bioscience

HQ: France Website
  • Description: Provider of CRISPR/Cas and engineered phage capsid-based antimicrobials and microbiome editing technologies to control bacterial ecosystems in humans and animals. Solutions include the GEM platform for in vivo gene editing, SSAM sequence-specific antimicrobials, FAME for therapeutic gene addition, and capabilities for gene removal, modification, and addition to eradicate resistant pathogens and modulate disease mechanisms.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Eligo Bioscience company profile →
🔒

2.M&A buyers

2.1 Potential strategic acquirers in the sector

🔒
🔒
🔒
🔒 View all strategic buyers with complete profiles
Start Free Trial →

2.2 - Strategic buyer groups for Selecta Biosciences

🔒

Buyer group 1: ████████ ████████

●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒 View all companies in this group
Request Free Trial Now →
🔒

Buyer group 2: ████████ ████████

●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒 View all companies in this group
Request Free Trial Now →
🔒

Buyer group 3: ████████ ████████

●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒 View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →

3. Investors and private equity firms

3.1 - Buyout funds investing in similar companies to Selecta Biosciences

2.2 - Growth funds investing in similar companies to Selecta Biosciences

🔒 View all growth equity funds with complete profiles
Start Free Trial →

4 - Top valuation comps for Selecta Biosciences

4.2 - Public trading comparable groups for Selecta Biosciences

🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →

4.3 - M&A Transactions similar to Selecta Biosciences

Selected M&A transactions

Date Target Description Buyer(s) Relevance EV EV/Revenue EV/EBITDA
🔒 View all M&A transactions with complete deal terms
Request Free Trial Now →

Frequently Asked Questions

About Selecta Biosciences

What does Selecta Biosciences do?

Selecta Biosciences is a provider of clinical-stage biotechnology focused on overcoming immunogenicity.

Who are Selecta Biosciences's competitors?

Selecta Biosciences's competitors and similar companies include SNIPR Biome, QuantRx Biomedical, Senti Bio, Yecuris, and Eligo Bioscience.

Where is Selecta Biosciences headquartered?

Selecta Biosciences is headquartered in United States.

How many employees does Selecta Biosciences have?

Selecta Biosciences has 1,000 employees 🔒.

When was Selecta Biosciences founded?

Selecta Biosciences was founded in 2010 🔒.

What sector and industry vertical is Selecta Biosciences in?

Selecta Biosciences is in the Enterprise Software 🔒 sector and industry

M&A Buyers & Acquirers for Selecta Biosciences

Who are the top strategic acquirers in Selecta Biosciences's sector and industry

Top strategic M&A buyers and acquirers in Selecta Biosciences's sector include ████████, ██████████, ██████, ████████, and ██████████ 🔒.

Which M&A buyer groups are most relevant for Selecta Biosciences?

Top strategic M&A buyers groups and sectors for Selecta Biosciences include █████████████████ , ████████████████, █████████████, ████████████, and ████████████████ 🔒.

Financial Investors investing in Selecta Biosciences's sector and industry vertical

Which are the top PE firms investing in Selecta Biosciences's sector and industry vertical?

Top PE firms investing in Selecta Biosciences's sector and industry vertical include ████████, ██████████, ████████, and ██████████ 🔒.

Who are the top buyout funds acquiring in Selecta Biosciences's sector and industry vertical?

Active PE funds and buyout funds acquiring companies in Selecta Biosciences's sector and industry vertical include █████████, ██████████, ████████████, and ████████████ 🔒.

Who are the top growth equity funds investing in companies in Selecta Biosciences's sector and industry vertical?

Growth funds and venture capital funds investing in companies similar to Selecta Biosciences include █████████, ██████████, ████████████, and ████████████ 🔒.

Valuation benchmarks of companies in Selecta Biosciences's sector and industry

Which are the key public companies that are relevant trading comps benchmarks for Selecta Biosciences?

The key public trading comparables and valuation benchmarks for Selecta Biosciences include █████████, ██████████, ████████████, and ████████████ 🔒.

Which are the key trading comparable groups for Selecta Biosciences for public valuation benchmarks?

Our platform tracks detailed public trading comparable groups and valuation benchmarks for Selecta Biosciences with complete valuation multiples, growth metrics, and profitability data. Access the full database to benchmark your company against relevant public comparables.

What are recent M&A transactions in Selecta Biosciences's sector and industry vertical?

Our platform tracks relevant M&A transactions comparables and valuation benchmarks for Selecta Biosciences with complete deal terms, valuation multiples, and strategic rationale. Access the full database to benchmark pricing and identify active acquirers.

What are recent capital raises and funding rounds in Selecta Biosciences's' sector and industry vertical?

Access recent funding rounds and capital raises in Selecta Biosciences's sector and industry vertical including growth equity, venture capital, and buyout investments. Our database includes round size, lead investors and valuations.

Ready to Find the Right Buyers?

Access complete buyer lists, valuation data, and M&A intelligence for Selecta Biosciences